| Year |
Citation |
Score |
| 2011 |
Craft S, Montine T, Baker L, Carter J, Green P, Wilkinson C. O1-04-07: Diets associated with type 2 diabetes and insulin resistance affect CSF mediators of Beta-amyloid clearance and toxicity Alzheimer's & Dementia. 7: S103-S103. DOI: 10.1016/J.Jalz.2011.05.254 |
0.314 |
|
| 2004 |
Simpkins JW, Yang SH, Liu R, Perez E, Cai ZY, Covey DF, Green PS. Estrogen-like compounds for ischemic neuroprotection. Stroke; a Journal of Cerebral Circulation. 35: 2648-51. PMID 15472107 DOI: 10.1161/01.Str.0000143734.59507.88 |
0.742 |
|
| 2004 |
Wen Y, Perez EJ, Green PS, Sarkar SN, Simpkins JW. nNOS is involved in estrogen mediated neuroprotection in neuroblastoma cells. Neuroreport. 15: 1515-8. PMID 15194886 DOI: 10.1097/01.Wnr.0000131674.92694.96 |
0.734 |
|
| 2004 |
Craft S, Kulstad J, Green P, Cook D, Watson GS, Baker LD, Reger M, Cholerton B, Asthana S, Plymate S. O2-02-06 Insulin effects on plasma beta-amyloid levels in normal adults and patients with AD Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80116-7 |
0.328 |
|
| 2001 |
Wang J, Green PS, Simpkins JW. Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. Journal of Neurochemistry. 77: 804-11. PMID 11331409 DOI: 10.1046/J.1471-4159.2001.00271.X |
0.537 |
|
| 2001 |
Green PS, Yang SH, Nilsson KR, Kumar AS, Covey DF, Simpkins JW. The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocrinology. 142: 400-6. PMID 11145603 DOI: 10.1210/Endo.142.1.7888 |
0.647 |
|
| 2000 |
Green PS, Perez EJ, Calloway T, Simpkins JW. Estradiol attenuation of beta-amyloid-induced toxicity: a comparison o. Journal of Neurocytology. 29: 419-23. PMID 11424958 DOI: 10.1023/A:1007173509470 |
0.724 |
|
| 2000 |
Green PS, Simpkins JW. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Annals of the New York Academy of Sciences. 924: 93-8. PMID 11193809 DOI: 10.1111/J.1749-6632.2000.Tb05566.X |
0.527 |
|
| 2000 |
Green PS, Yang SH, Simpkins JW. Neuroprotective effects of phenolic A ring oestrogens. Novartis Foundation Symposium. 230: 202-13; discussion 2. PMID 10965510 DOI: 10.1002/0470870818.Ch15 |
0.672 |
|
| 2000 |
Green PS, Simpkins JW. Neuroprotective effects of estrogens: potential mechanisms of action. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 18: 347-58. PMID 10817919 DOI: 10.1016/S0736-5748(00)00017-4 |
0.6 |
|
| 2000 |
Persky AM, Green PS, Stubley L, Howell CO, Zaulyanov L, Brazeau GA, Simpkins JW. Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 223: 59-66. PMID 10632962 DOI: 10.1046/J.1525-1373.2000.22308.X |
0.682 |
|
| 1999 |
Zaulyanov LL, Green PS, Simpkins JW. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens. Cellular and Molecular Neurobiology. 19: 705-18. PMID 10456232 DOI: 10.1023/A:1006948921855 |
0.565 |
|
| 1998 |
Gridley KE, Green PS, Simpkins JW. A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Molecular Pharmacology. 54: 874-80. PMID 9804622 DOI: 10.1124/Mol.54.5.874 |
0.594 |
|
| 1998 |
Simpkins JW, Rabbani O, Shi J, Panickar KS, Green PS, Day AL. A system for the brain-enhanced delivery of estradiol: an assessment of its potential for the treatment of Alzheimer's disease and stroke. Die Pharmazie. 53: 505-11. PMID 9741059 |
0.639 |
|
| 1998 |
Green P, Dawson R, Wallace DR, Owens J. Treatment of rat brain membranes with taurine increases radioligand binding. Advances in Experimental Medicine and Biology. 442: 377-83. PMID 9635054 DOI: 10.1007/978-1-4899-0117-0_47 |
0.369 |
|
| 1998 |
Green PS, Gridley KE, Simpkins JW. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience. 84: 7-10. PMID 9522357 DOI: 10.1016/S0306-4522(97)00595-2 |
0.615 |
|
| 1997 |
Gridley KE, Green PS, Simpkins JW. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Research. 778: 158-65. PMID 9462888 DOI: 10.1016/S0006-8993(97)01056-1 |
0.526 |
|
| 1997 |
Green PS, Gordon K, Simpkins JW. Phenolic A ring requirement for the neuroprotective effects of steroids. The Journal of Steroid Biochemistry and Molecular Biology. 63: 229-35. PMID 9459189 DOI: 10.1016/S0960-0760(97)00124-6 |
0.563 |
|
| 1997 |
Simpkins JW, Green PS, Gridley KE, Singh M, de Fiebre NC, Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. The American Journal of Medicine. 103: 19S-25S. PMID 9344403 DOI: 10.1016/S0002-9343(97)00260-X |
0.728 |
|
| 1997 |
Green PS, Bishop J, Simpkins JW. 17α-Estradiol Exerts Neuroprotective Effects on SK-N-SH Cells The Journal of Neuroscience. 17: 511-515. DOI: 10.1523/Jneurosci.17-02-00511.1997 |
0.511 |
|
| 1996 |
Green PS, Gridley KE, Simpkins JW. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neuroscience Letters. 218: 165-8. PMID 8945754 DOI: 10.1016/S0304-3940(96)13148-7 |
0.581 |
|
| Show low-probability matches. |